Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes: Results from the botnia study

Diabetes Care

Volumn 32, Issue 2, 2009, Pages 281-286

  Abdul Ghani, Muhammad A ^a   Lyssenko, Valeriya ^b   Tuomi, Tiinamaija ^b   Defronzo, Ralph A ^a   Groop, Leif ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b LUND UNIVERSITY DIABETES CENTRE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CORRELATION COEFFICIENT; DIET RESTRICTION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PREDICTION; PREDICTOR VARIABLE; RECEIVER OPERATING CHARACTERISTIC; BIOLOGICAL MODEL; BLOOD; EATING; GLUCOSE TOLERANCE TEST; METABOLISM; MIDDLE AGED; REFERENCE VALUE; RISK FACTOR; ROC CURVE; SECRETION; STATISTICS;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; EATING; FASTING; FEMALE; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MODELS, BIOLOGICAL; REFERENCE VALUES; RISK FACTORS; ROC CURVE;

EID: 61849140099     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-1264     Document Type: Article

References (25)

1. Unwin N, Shaw J, Zimmet P, Alberti KGMM: Impaired glucose tolerance and impaired fasting glycemia: the current status on definition and intervention. Diabet Med 19:708-723, 2002
2. Diabetes Prevention Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403, 2002
3. Stern MP, Williams K, Haffner SM: Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Ann Intern Med 136: 575-581, 2002
4. Aekplakorn W, Bunnag P, Woodward M, Sritara P, Cheepudomwit S, Yamwong S, Yipintsoi T, Rajatanavin R: A risk score for predicting incident diabetes in the Thai population. Diabetes Care 29:1872-1877, 2006
5. Wannamethee SG, Shaper AG, Lennon L, Morris RW: Metabolic syndrome vs Fra- mingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 165: 2644-2650, 2005
6. Kanaya AM, Wassel Fyr CL, de Rekeneire N, Shorr RI, Schwartz AV, Goodpaster BH, Newman AB, Harris T, Barrett-Connor E: Predicting the development of diabetes in older adults: the derivation and validation of a prediction rule. Diabetes Care 28:404-408, 2005
7. McNeely MJ, Boyko EJ, Leonetti DL, Kahn SE, Fujimoto WY: Comparison of a clinical model, the oral glucose tolerance test, and fasting glucose for prediction of type 2 diabetes risk in Japanese Americans. Diabetes Care 26:758-763, 2003
8. Lindstrom J, Tuomilehto J: The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 26:725-731, 2003
9. Abdul-Ghani MA, Williams K, DeFronzo R, Stern M: Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose. Diabetes Care 29:1613-1618, 2006
10. Abdul-Ghani MA, Abdul-Ghani T, Ali N, DeFronzo RA: One hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for type 2 diabetes. Diabetes Care 31:1650-1655, 2008
11. Abdul-Ghani MA, Tripathy D, DeFronzo RA: Contributions of β-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 29: 1130-1139, 2006
12. DeFronzo RA: Lilly Lecture 1987: The triumvirate: β-cell, muscle, liver: a collusion responsible for NIDDM. Diabetes 37:667-687, 1988
13. DeFronzo RA: Pathogenesis of type 2 diabetes. Med Clin North Am 88:787-835, 2004
14. Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM, San Antonio Heart Study. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio Heart Study. Diabetes Care 26: 3153-3159, 2003
15. Abdul-Ghani MA, Williams K, DeFronzo RA, Stern M: What is the best predictor of future type 2 diabetes? Diabetes Care 30: 1544-1548, 2007
16. Abdul-Ghani MA, Matsuda M, Sabbah M, Jenkinson C, Richardson D, Kaku K, De-Fronzo RA: The relative contributions of insulin resistance and β cell failure to the transition from normal to impaired glucose tolerance varies in different ethnic groups. Diabetes Metab Syn Res Rev 1:105-112, 2007
17. Groop L, Forsblom C, Lehtovirta M, Tuomi T, Karanko S, Nissen M, Ehrn- strom BO, Forsen B, Isomaa B, Snickars B, Taskinen MR: Metabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex-specific parental effects. Diabetes 45:1585-1593, 1996
18. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
19. Grundy SM, Cleeman JI, Daniels SR, Do-nato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735-2752, 2005
20. Matsuda M, DeFronzo RA: Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic glucose clamp. Diabetes Care 22:1462-1470, 1999
21. Clark LA, Pregibon D: Tree model analysis. In Statistical Models. Chambers JM, Hastie TJ, Eds. Pacific Grove, CA, Wads- worth & Brooks, 1992, p. 377-420
22. DeLong ER, DeLong DM, Clarke-Pearson DL: Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837-845, 1988
23. Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R, Zinman B, American Diabetes Association: Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 30:753-759, 2007
24. Abdul-Ghani MA, Jenkinson CP, Richardson DK, Tripathy D, DeFronzo RA: Insulin secretion and insulin action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study (VEGAS). Diabetes 55:1430-1435, 2006
25. Abdul-Ghani MA, Matsuda M, Jani R, Jen-kinson CP, Coletta DK, Kaku K, De-Fronzo RA: The relationship between fasting hyperglycemia and insulin secretion in subjects with normal or impaired glucose tolerance. Am J Physiol Endocrinol Metab 295:E401-E406, 2008